Stay updated on MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial

Sign up to get notified when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page history shows an added Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link, along with a prior Revision: v3.3.2; These are admin-level updates to the page metadata/footer and do not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-24T15:00:15.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.3.2 added to the page history, replacing v3.2.0 and reflecting a platform/UI update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T14:45:06.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page no longer displays a government funding and operating status notice that appeared at the top; this change does not affect the study record or its data.
    Difference
    0.5%
    Check dated 2025-11-18T07:27:32.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The old and new screenshots show minor UI/layout adjustments on the Record History page, while the version list and navigation remain unchanged. There is no change to core study data, status, or substantive content.
    Difference
    0.1%
    Check dated 2025-11-03T21:33:23.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    10%
    Check dated 2025-10-06T07:16:24.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.2%
    Check dated 2025-09-29T03:47:03.000Z thumbnail image

Stay in the know with updates to MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MEK162 vs Dacarbazine in NRAS+ Melanoma Clinical Trial page.